BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17700588)

  • 1. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).
    Prockop DJ
    Clin Pharmacol Ther; 2007 Sep; 82(3):241-3. PubMed ID: 17700588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perivascular ancestors of adult multipotent stem cells.
    Corselli M; Chen CW; Crisan M; Lazzari L; Péault B
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1104-9. PubMed ID: 20453168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
    Phinney DG; Prockop DJ
    Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental definition of MSCs: new insights into pending questions.
    Huang S; Leung V; Peng S; Li L; Lu FJ; Wang T; Lu W; Cheung KM; Zhou G
    Cell Reprogram; 2011 Dec; 13(6):465-72. PubMed ID: 21919705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic applications of mesenchymal stromal cells.
    Brooke G; Cook M; Blair C; Han R; Heazlewood C; Jones B; Kambouris M; Kollar K; McTaggart S; Pelekanos R; Rice A; Rossetti T; Atkinson K
    Semin Cell Dev Biol; 2007 Dec; 18(6):846-58. PubMed ID: 18024097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.
    Pytlík R; Stehlík D; Soukup T; Kalbácová M; Rypácek F; Trc T; Mulinková K; Michnová P; Kideryová L; Zivný J; Klener P; Veselá R; Trnený M; Klener P
    Biomaterials; 2009 Jul; 30(20):3415-27. PubMed ID: 19362364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.
    Djouad F; Bouffi C; Ghannam S; Noël D; Jorgensen C
    Nat Rev Rheumatol; 2009 Jul; 5(7):392-9. PubMed ID: 19568253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of p21(Cip1/Waf1) enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells.
    Yew TL; Chiu FY; Tsai CC; Chen HL; Lee WP; Chen YJ; Chang MC; Hung SC
    Aging Cell; 2011 Apr; 10(2):349-61. PubMed ID: 21342417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multipotent stromal cells: controversial impact on tumor development and metastasis].
    Apparailly F; Jorgensen C; Lazennec G
    Med Sci (Paris); 2008 Apr; 24(4):359-60. PubMed ID: 18405628
    [No Abstract]   [Full Text] [Related]  

  • 11. Lung Multipotent Stem Cells of Mesenchymal Nature: Cellular Basis, Clinical Relevance, and Implications for Stem Cell Therapy.
    Klein D
    Antioxid Redox Signal; 2021 Jul; 35(3):204-216. PubMed ID: 33167666
    [No Abstract]   [Full Text] [Related]  

  • 12. Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: limitations for autologous cell replacement strategies.
    Hermann A; List C; Habisch HJ; Vukicevic V; Ehrhart-Bornstein M; Brenner R; Bernstein P; Fickert S; Storch A
    Cytotherapy; 2010; 12(1):17-30. PubMed ID: 19878082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester human decidua contains a population of mesenchymal stem cells.
    Dimitrov R; Kyurkchiev D; Timeva T; Yunakova M; Stamenova M; Shterev A; Kyurkchiev S
    Fertil Steril; 2010 Jan; 93(1):210-9. PubMed ID: 19006798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells as therapeutics.
    Parekkadan B; Milwid JM
    Annu Rev Biomed Eng; 2010 Aug; 12():87-117. PubMed ID: 20415588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor origin of multipotent adult progenitor cells in radiation chimeras.
    Reyes M; Li S; Foraker J; Kimura E; Chamberlain JS
    Blood; 2005 Nov; 106(10):3646-9. PubMed ID: 16099880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding autologous multipotent mesenchymal bone marrow stromal cells.
    Brinchmann JE
    J Neurol Sci; 2008 Feb; 265(1-2):127-30. PubMed ID: 17560612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).
    Prockop DJ; Kota DJ; Bazhanov N; Reger RL
    J Cell Mol Med; 2010 Sep; 14(9):2190-9. PubMed ID: 20716123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.
    Tyndall A; Uccelli A
    Bone Marrow Transplant; 2009 Jun; 43(11):821-8. PubMed ID: 19308035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
    Nadeau S; Cheng A; Colmegna I; Rodier F
    Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.